Float
Float Health is a platform for on-demand home infusion nurses, streamlining scheduling, charting, and invoicing for specialty patient care.
Secondary Market Price
Secondary Market Price
How Float Measures Up
To help you manage your Float equity, Prospect has run the company through our machine learning model.
Prospect Rating
TBD
We're still in the process of analyzing Float's potential. Check back with us soon for our official rating and what we think the company will be worth in four years.
Exit Risk
TBD
We are still gathering data on Float to train our machine learning model. Check back soon for our exit risk rating for Float!
Funding Stage
Series A
A Series A company like Float has moved past the initial startup chaos and is now focused on scaling its operations. For you, this translates to an opportunity to join a company with a proven concept while still being early enough to make a significant impact.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Float's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Float Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Float's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Float Health operates an on-demand platform that provides infusion nurses for patient care in their homes. The company connects specialty pharmacies with a nationwide network of nurses, offering an AI-powered portal to streamline workflows, documentation, and nurse staffing. This system is used by over 100 partners, including major specialty pharmacies like Optum, CVS, and Option Care, and has been used to complete more than 50,000 home visits. Float Health was founded in 2021 by former ER nurse Ryan Johnson, whose personal experience caring for his father with a chronic illness shaped the company's focus on addressing challenges in chronic care delivery and hospital overcrowding.
The company plans to continue expanding its data-driven models to improve patient outcomes and reduce costs, while growing its digital marketplace for nurses and specialty pharmacies. A recent key development for the company was its $10 million Series A funding round in April 2024, led by Canvas Prime. In recent months, CEO Ryan Johnson has also appeared on industry podcasts and published op-eds in publications like MedCity News to discuss the role of home infusion therapy in the broader healthcare system.
- Y Combinator
- Canvas Ventures
- Co-Founder, Glenn Rogers
- Co-Founder, Lars Gelfan
- Co-Founder, Joseph Schmitt
- Co-Founder, Yaron Schoen
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Float worth joining?
Deciding to join a startup like Float depends on your personal career goals and risk tolerance. You should evaluate the company's growth prospects, leadership, and the specifics of your compensation package, including the equity offered.
What should I do with my Float stock?
Managing private company stock involves complex decisions around when to exercise options and how to minimize taxes. Platforms like Prospect can help you create a personalized strategy to optimize the value of your Float equity.
Can you sell Float stock?
Selling stock in a private company like Float is possible, typically through secondary markets or company-organized tender offers. Tools like Prospect's tender offer tools can help you navigate these sales and determine which shares are the most tax-optimal to sell.
How can I find the value of my Float stock?
The value of private stock isn't publicly listed, but it can be estimated based on the company's last 409A valuation and secondary market transactions. To get a more sophisticated forecast, you can use platforms like Prospect, which use predictive models to project your equity's future value.
What is Float's equity worth?
The total value of Float's equity is determined by the valuation set during its most recent funding round. For an individual employee, understanding the potential worth of your specific holdings requires modeling and forecasting, which can be done with specialized equity management tools.
What is Float's stock ticker symbol?
As a private company, Float is not traded on a public stock exchange and therefore does not have a stock ticker symbol. A ticker symbol will only be assigned if and when the company completes an Initial Public Offering (IPO).
Can I buy or sell Float stock?
Selling private Float stock is sometimes possible through secondary markets or tender offers, and platforms like Prospect can help optimize these sales. Buying shares is typically restricted to accredited investors and is also done through secondary markets, when available.
What is the criteria to buy or invest in Float stock?
Investing in a private company like Float is typically restricted to accredited investors who meet specific income or net worth thresholds defined by financial regulators. These investment opportunities are usually offered through private placements or secondary market platforms.
